India becoming an attractive option for global pharmaceutical supply chain: Macquarie Report

India's CRDMO industry is projected to grow from USD 7 billion to USD 14 billion by 2028, driven by pharmaceutical outsourcing and regulatory support. The industry's growth could reach a high-teens CAGR due to factors like the US Biosecure Act, potentially pushing it to USD 22 billion by 2030.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/J4TldtY
via IFTTT